⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13775052 | 1.00 | — | — | |
| SCHEMBL3809572 | 0.93 | — | — | |
| SCHEMBL3813369 | 0.93 | — | — | |
| SCHEMBL3818053 | 0.93 | — | — | |
| SCHEMBL3811491 | 0.93 | — | — | |
| SCHEMBL4117887 | 0.93 | — | — | |
| SCHEMBL4104964 | 0.93 | — | — | |
| SCHEMBL4104973 | 0.93 | — | — | |
| SCHEMBL13775054 | 0.91 | — | — | |
| SCHEMBL3819067 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1819681-B1 | 7-(2H-PYRAZOL-3-YL)-3,5-DIHYDROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | WARNER LAMBERT CO (US) | 2009-08-12 | — | — | EP | claimed |
| US-20090170852-A1 | NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS | PFIZER INC. | 2009-07-02 | — | — | US | claimed |
| EP-1819681-A1 | 7-(2H-PYRAZOL-3-YL)-3,5-DIHYDROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | Warner-Lambert Company LLC (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2006056845-A1 | 7-(2H-PYRAZOL-3-YL)-3, 5-DIHYROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | WARNER-LAMBERT COMPANY LLC (US) | 2006-06-01 | — | — | WO | claimed |
| US-20060111422-A1 | Novel pyrazole-based HMG CoA reductase inhibitors | WARNER-LAMBERT COMPANY LLC | 2006-05-25 | — | — | US | claimed |
| EP-1819681-B1 | 7-(2H-PYRAZOL-3-YL)-3,5-DIHYDROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | WARNER LAMBERT CO (US) | 2009-08-12 | — | — | EP | disclosed |
| US-20090170852-A1 | NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS | PFIZER INC. | 2009-07-02 | — | — | US | disclosed |
| US-7446121-B2 | Pyrazole-based HMG CoA reductase inhibitors | PFIZER INC. (US) | 2008-11-04 | — | — | US | disclosed |
| EP-1819681-A1 | 7-(2H-PYRAZOL-3-YL)-3,5-DIHYDROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | Warner-Lambert Company LLC (US) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006056845-A1 | 7-(2H-PYRAZOL-3-YL)-3, 5-DIHYROXY-HEPTANOIC ACID DERIVATIVES AS HMG CO-A REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA | WARNER-LAMBERT COMPANY LLC (US) | 2006-06-01 | — | — | WO | disclosed |
| US-20060111422-A1 | Novel pyrazole-based HMG CoA reductase inhibitors | WARNER-LAMBERT COMPANY LLC | 2006-05-25 | — | — | US | disclosed |